دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Putting the burden of skin diseases on the global map
C. Flohr R. Hay
doi : 10.1111/bjd.19704
Volume 184, Issue 2, February 2021, Pages: 189-190
New oral antifungals for onychomycosis: interesting potential and the need for comparative effectiveness trials
J.S. Barbieri
doi : 10.1111/bjd.19306
Volume 184, Issue 2, February 2021, Pages: 191
Extent of ulceration in cutaneous melanoma: is this biomarker ready for primetime?
M.J. Wilkinson D.E. Gyorki
doi : 10.1111/bjd.19386
Volume 184, Issue 2, February 2021, Pages: 192-93
A different finding on whether naevus numbers change during adulthood
A.E. Cust
doi : 10.1111/bjd.19619
Volume 184, Issue 2, February 2021, Pages: 193
Association of skin diseases, biological treatment and COVID?19 during the first wave of the pandemic
M.A. Descalzo I. Garcia?Doval
doi : 10.1111/bjd.19683
Volume 184, Issue 2, February 2021, Pages: 194
While the current coronavirus disease 2019 (COVID?19) pandemic increases and spreads all over the world, the availability of large reliable datasets, in a short time or in real time is limited. In response to this challenge, the Ministry of Health from South Korea launched a highly commendable open initiative, making large health datasets accessible, and enabling researchers and clinicians to access data to control and fight the pandemic.
Are existing quality?of?life instruments in cutaneous T?cell lymphoma of sufficient quality?
M. Gabes
doi : 10.1111/bjd.19408
Volume 184, Issue 2, February 2021, Pages: 195
Cutaneous T?cell lymphoma (CTCL) is a rare type of non?Hodgkin lymphoma. However, non?Hodgkin lymphoma is ranked as the seventh most common cancer in the USA.1 In CTCL, mutated T cells migrate to the skin, and lesions on the skin tend to appear. Mycosis fungoides (MF) and Sézary syndrome (SS) are the most prevalent forms of CTCL.
There is still a place for tumour?targeted therapies in Merkel cell carcinoma in the era of immune checkpoint inhibitors
M. Samimi J. Becker
doi : 10.1111/bjd.19247
Volume 184, Issue 2, February 2021, Pages: 195-197
The influence of sex, age and sunlight exposure on mutational processes in melanoma
A.E. Toland
doi : 10.1111/bjd.19336
Volume 184, Issue 2, February 2021, Pages: 197-198
Mapping the burden of onchocercal skin disease
M.E. Murdoch
doi : 10.1111/bjd.19143
Volume 184, Issue 2, February 2021, Pages: 199-207
Onchocerciasis is a neglected tropical disease caused by a nematode parasite, Onchocerca volvulus, and transmitted by bites of Simulium blackflies which breed near fast?flowing rivers. In humans, thousands of microfilariae (immature worms) migrate to the skin and eyes where they cause pathology.
Global evidence on occupational sun exposure and keratinocyte cancers: a systematic review
T. Loney M.S. Paulo A. Modenese F. Gobba T. Tenkate D.C. Whiteman A.C. Green S.M. John
doi : 10.1111/bjd.19152
Volume 184, Issue 2, February 2021, Pages: 208-218
Individual studies have suggested that the association between occupational exposure to solar ultraviolet radiation (UVR) and the development of keratinocyte cancers (KCs) may only be valid in populations of European ancestry living in certain geographical regions.
Reviewing the global burden of acne: how could we improve care to reduce the burden?
A.M. Layton D. Thiboutot J. Tan
doi : 10.1111/bjd.19477
Volume 184, Issue 2, February 2021, Pages: 219-225
Acne (also known as acne vulgaris) remains the most common inflammatory dermatosis treated worldwide, as estimated by global skin disease prevalence studies. Latest reports suggest that the prevalence may be increasing in adolescents and adults, particularly female adults.
The global burden of chronic urticaria for the patient and society
M. Gonçalo A. Gimenéz?Arnau M. Al?Ahmad M. Ben?Shoshan J.A. Bernstein L.F. Ensina D. Fomina C.A. Galvàn K. Godse C. Grattan M. Hide C.H. Katelaris M. Khoshkhui E. Kocatürk K. Kulthanan I. Medina I. Nasr J. Peter P. Staubach L. Wang K. Weller M. Maurer
doi : 10.1111/bjd.19561
Volume 184, Issue 2, February 2021, Pages: 226-236
Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young and middle?aged women. It usually lasts for several years (> 1 year in 25–75% of patients) and often takes > 1 year before effective management is implemented.
Estimating the global burden of scabies: what else do we need?
V. Cox L.C. Fuller D. Engelman A. Steer R.J. Hay
doi : 10.1111/bjd.19170
Volume 184, Issue 2, February 2021, Pages: 237-242
Scabies is one of the most common disorders identified in any estimate of global skin disease prevalence. Furthermore, quantifying its impact on individuals and societies has been problematic. There has been a lack of clear case definitions and laboratory tests.
Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender
I.Y.K. Iskandar R. Parisi C.E.M. Griffiths D.M. Ashcroft on behalf of the Global Psoriasis Atlas
doi : 10.1111/bjd.19169
Volume 184, Issue 2, February 2021, Pages: 243-258
There is a lack of any overview of changes over time and variation in the epidemiology of psoriasis with age and between genders.
Guselkumab vs. secukinumab for the treatment of moderate?to?severe psoriasis: a critical appraisal
M.T. Wan J. Takeshita
doi : 10.1111/bjd.19216
Volume 184, Issue 2, February 2021, Pages: 259-260
No Abstract
Protective effects of dietary fish?oil supplementation on skin inflammatory and oxidative stress biomarkers induced by fine particulate air pollution: a pilot randomized, double?blind, placebo?controlled trial
Z. Lin Y. Niu Y. Jiang B. Chen L. Peng T. Mi N. Huang W. Li D. Xu R. Chen H. Kan
doi : 10.1111/bjd.19156
Volume 184, Issue 2, February 2021, Pages: 261-269
Exposure to fine particulate matter (with an aerodynamic diameter ? 2·5 ?m, PM2·5) air pollution has been associated with skin?related diseases or disorders.
A phase II, randomized, double?blind, placebo?controlled, dose?ranging study to evaluate the efficacy and safety of VT?1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail
B. Elewski S. Brand T. Degenhardt S. Curelop R. Pollak R. Schotzinger A. Tavakkol
doi : 10.1111/bjd.19224
Volume 184, Issue 2, February 2021, Pages: 270-280
Onychomycosis is a fungal disease that affects the fingernails and toenails and is predominantly caused by dermatophytes. VT?1161 is a novel inhibitor of fungal CYP51 through the inhibition of lanosterol demethylase, and has demonstrated potent activity against Trichophyton rubrum and Trichophyton mentagrophytes.
The prognostic impact of the extent of ulceration in patients with clinical stage I–II melanoma: a multicentre study of the Italian Melanoma Intergroup (IMI)
F. Portelli F. Galli L. Cattaneo M. Cossa V. De Giorgi G. Forte G. Fraternali Orcioni A. Gianatti A. Indini A. Labianca A. Maurichi B. Merelli M.C. Montesco M. Occelli R. Patuzzo D. Piazzalunga J. Pigozzo P. Quaglino S. Ribero R. Salvatori D. Saraggi P. Sena R. Senetta B. Valeri M. Tanaka M. Fukayama G. Palmieri M. Mandalà D. Massi for the Italian Melanoma Intergroup (IMI)
doi : 10.1111/bjd.19120
Volume 184, Issue 2, February 2021, Pages: 281-288
The presence of ulceration has been recognized as an adverse prognostic factor in primary cutaneous melanoma (PCM).
Natural history of naevi: a two?wave study
S. Ribero D. Zugna T. Spector V. Bataille
doi : 10.1111/bjd.19171
Volume 184, Issue 2, February 2021, Pages: 289-295
Naevi number changes with age. Thus, a better understanding of naevus biology will shed more light on the genetic and environmental factors involved in melanoma development.
Association of COVID?19 with skin diseases and relevant biologics: a cross?sectional study using nationwide claim data in South Korea
S.I. Cho Y.E. Kim S.J. Jo
doi : 10.1111/bjd.19507
Volume 184, Issue 2, February 2021, Pages: 296-303
As the coronavirus disease 2019 (COVID?19) pandemic has spread, information about COVID?19 and skin disease or related biologics is still lacking.
The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017
M.R. Laughter M.B.C. Maymone S. Mashayekhi B.W.M. Arents C. Karimkhani S.M. Langan R.P. Dellavalle C. Flohr
doi : 10.1111/bjd.19580
Volume 184, Issue 2, February 2021, Pages: 304-309
The Global Burden of Disease (GBD) Study provides an annually updated resource to study disease?related morbidity and mortality worldwide.
Current measures are not sufficient: an interview?based qualitative assessment of quality of life in cutaneous T?cell lymphoma
T.S. Bhat C.M. Herbosa A.R. Rosenberg O. Sogade D.B. Jeffe N. Mehta?Shah Y.R. Semenov A.C. Musiek
doi : 10.1111/bjd.19298
Volume 184, Issue 2, February 2021, Pages: 310-318
Cutaneous T?cell lymphoma (CTCL) negatively impacts quality of life (QoL), but existing QoL questionnaires may not comprehensively reflect patients’ experience.
High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma
T. Akaike J. Qazi A. Anderson F.S. Behnia M.M. Shinohara G. Akaike D.S. Hippe H. Thomas S.R. Takagishi K. Lachance S.Y. Park E.S. Tarabadkar J.G. Iyer A. Blom U. Parvathaneni H. Vesselle P. Nghiem S. Bhatia
doi : 10.1111/bjd.19150
Volume 184, Issue 2, February 2021, Pages: 319-327
Merkel cell carcinoma (MCC) is an aggressive, high?grade, cutaneous neuroendocrine tumour (NET). Agents blocking programmed death 1/programmed death ligand 1 have efficacy in metastatic MCC (mMCC), but half of patients do not derive durable benefit. Somatostatin analogues (SSAs) are commonly used to treat low? and moderate?grade NETs that express somatostatin receptors (SSTRs).
Molecular subtype, biological sex and age shape melanoma tumour evolution
M. Lotz T. Budden S.J. Furney A. Vir?s
doi : 10.1111/bjd.19128
Volume 184, Issue 2, February 2021, Pages: 328-337
Many cancer types display sex and age disparity in incidence and outcome. The mutational load of tumours, including melanoma, varies according to sex and age. However, there are no tools to explore systematically whether clinical variables such as age and sex determine the genomic landscape of cancer.
Publishing addiction: a behavioural disorder with specific characteristics
A.Y. Finlay
doi : 10.1111/bjd.19500
Volume 184, Issue 2, February 2021, Pages: 338-339
Routine liver ultrasound screening does not alter clinical management in a cohort study of multiple cutaneous infantile haemangioma
C. Mahon K. McHugh N. Alband D. Rampling N. Sebire E. Williamson M. Glover V.A. Kinsler
doi : 10.1111/bjd.19472
Volume 184, Issue 2, February 2021, Pages: 340-341
Increased expression of interleukin?23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment
M. Napolitano G. Caiazzo G. Fabbrocini A. Balato R. Di Caprio E. Scala M. Scalvenzi C. Patruno
doi : 10.1111/bjd.19459
Volume 184, Issue 2, February 2021, Pages: 341-343
Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches
C.B. Ardon C. Wang E.P. Prens K.R. van Straalen
doi : 10.1111/bjd.19462
Volume 184, Issue 2, February 2021, Pages: 343-345
Transient response to nivolumab and relapse after infliximab in a patient with primary cutaneous CD8?positive aggressive epidermotropic cytotoxic T?cell lymphoma
F. Toussaint M. Erdmann E. Grosch S. Schliep G. Schuler R. Dummer L. Heinzerling
doi : 10.1111/bjd.19470
Volume 184, Issue 2, February 2021, Pages: 345-347
Recurrent MVD mutation in European patients with disseminated porokeratosis
M. Saleva?Stateva K. Technau?Hafsi L. Frommherz G. Grüninger S. J?gle L. Dourmishev L. Miteva J. Fischer C. Has
doi : 10.1111/bjd.19467
Volume 184, Issue 2, February 2021, Pages: 347-348
A review of current phase III clinical trials of plaque psoriasis: under?representation of nonwhite participants and need for reform
V.D. Reddy B.A. Myers S.Y. Chan Q.G. Thibodeaux N.D. Brownstone T. Bhutani W. Liao J.C. Lester J.Y. Koo
doi : 10.1111/bjd.19468
Volume 184, Issue 2, February 2021, Pages: 348-350
Weekly administration of brodalumab in hidradenitis suppurativa: an open?label cohort study
J.W. Frew K. Navrazhina M. Sullivan?Whalen P. Gilleaudeau S. Garcet J.G. Krueger
doi : 10.1111/bjd.19478
Volume 184, Issue 2, February 2021, Pages: 350-352
Quantification of skin sensitivity to ultraviolet radiation using ultrawideband optoacoustic mesoscopy
B. Hindelang J. Aguirre A. Berezhnoi T. Biedermann U. Darsow B. Eberlein V. Ntziachristos
doi : 10.1111/bjd.19463
Volume 184, Issue 2, February 2021, Pages: 352-354
Intralesional rituximab in the treatment of indolent primary cutaneous B?cell lymphoma
A. Chirico M.H. Henderson Berg D. Roberge K. Pehr
doi : 10.1111/bjd.19490
Volume 184, Issue 2, February 2021, Pages: 354-356
Locoregional nodal extension does not impair prognosis of primary cutaneous anaplastic lymphomas
M. D’Incan S. Ingen?Housz?Oro M. Beylot?Barry P. Joly F. Grange G. Quereux I. Templier C. Ram?Wolff H. Adamski C. Lambert C. Descours
doi : 10.1111/bjd.19495
Volume 184, Issue 2, February 2021, Pages: 356-358
Characteristics modifying response to biological treatments for psoriasis: considering subgroups in network meta?analysis
R. Wade S. Sharif?Hurst C. Smith S. Dias
doi : 10.1111/bjd.19494
Volume 184, Issue 2, February 2021, Pages: 358-359
How to break resistance to hedgehog inhibitors in advanced basal cell carcinoma?
E. Ramelyte G. Restivo L. Imhof M.C. N?geli R. Dummer
doi : 10.1111/bjd.19501
Volume 184, Issue 2, February 2021, Pages: 359-361
Reproductive factors, hormone use and melanoma risk: an Australian prospective cohort study
C. M. Olsen N. Pandeya J. C. Dusingize B. S. Thompson A. C. Green R. E. Neale P. M. Webb D. C. Whiteman for the QSkin Study
doi : 10.1111/bjd.19498
Volume 184, Issue 2, February 2021, Pages: 351-363
Patterns of cutaneous immune?related adverse events in adults and children with advanced sarcoma: a retrospective cohort study
L.L. Thompson M.S. Chang L. McCormack N. Polyakov J. Yoon H. Song J.T. Huang S.T. Chen
doi : 10.1111/bjd.19540
Volume 184, Issue 2, February 2021, Pages: 363-365
The epidemiology of malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK from 2004 to 2014: a population?based cohort analysis using the Clinical Practice Research Datalink
F.N. Mirza S. Yumeen F.M. Walter
doi : 10.1111/bjd.19542
Volume 184, Issue 2, February 2021, Pages: 365-367
Identification of clonal skin myeloid cells by next?generation sequencing in myelodysplasia cutis
J. Delaleu M. Battistella K. Rathana M.?D. Vignon?Pennamen C. Laurent C. Ram?Wolff P. Fenaux M. Jachiet E. Zuelgaray M. Bagot J.?D. Bouaziz A. de Masson
doi : 10.1111/bjd.19547
Volume 184, Issue 2, February 2021, Pages: 367-369
Evaluation of malignancy risk in scleroderma by antibody profile
C. Lertphanichkul G.P. Smith
doi : 10.1111/bjd.19549
Volume 184, Issue 2, February 2021, Pages: 369-371
A novel nondrug SFRP1 antagonist inhibits catagen development in human hair follicles ex vivo
M. Bertolini J. Chéret D. Pinto N. Hawkshaw L. Ponce H. Erdmann F. Jimenez W. Funk R. Paus
doi : 10.1111/bjd.19552
Volume 184, Issue 2, February 2021, Pages: 371-373
Comorbid acne inversa and Dowling–Degos disease due to a single NCSTN mutation: is there enough evidence?
M.A. Hermasch M.P. Sch?n J. Frank
doi : 10.1111/bjd.19539
Volume 184, Issue 2, February 2021, Pages: 374
Comorbid acne inversa and Dowling–Degos disease due to a single NCSTN mutation: is there enough evidence? Reply from the authors
S. Garcovich P.M. Tricarico C.N. Meddour G. Giovanardi K. Peris S. Crovella M. Boniotto
doi : 10.1111/bjd.19543
Volume 184, Issue 2, February 2021, Pages: 375-376
The science and rationale of arriving at the correct drug and dosimetry of griseofulvin, fluconazole, terbinafine and itraconazole in superficial dermatophyte infections: an important step before a pragmatic trial
K. Sardana S.R. Mathachan
doi : 10.1111/bjd.19562
Volume 184, Issue 2, February 2021, Pages: 376-377
Severe skin diseases in children beyond topical therapy
S. George
doi : 10.1111/bjd.19612
Volume 184, Issue 2, February 2021, Pages: 377-378
Obituary: Vale Robert Alan Briggaman MD 1934–2020
Dedee F. Murrell Jay Cheesborough David T. Woodley
doi : 10.1111/bjd.19404
Volume 184, Issue 2, February 2021, Pages: 379-380
Congenital bilateral scar?like lesions on the face
A. Durack S.T. Holden N.P. Burrows
doi : 10.1111/bjd.19328
Volume 184, Issue 2, February 2021, Pages: e29
Topical imiquimod monotherapy for a recurrent lesion of Merkel cell carcinoma
H. Miura M. Takada M. Fujiwara S. Fujiwara
doi : 10.1111/bjd.19402
Volume 184, Issue 2, February 2021, Pages: e30
Ruptured hair follicles of the scalp mimicking malignant melanoma
S. Elsarafy H. Tobiss D. Veitch M. Bhuchar M. Khan A. Patel
doi : 10.1111/bjd.19476
Volume 184, Issue 2, February 2021, Pages: e31
Somatostatin receptors: an alternative treatment target for advanced Merkel cell carcinoma
doi : 10.1111/bjd.19723
Volume 184, Issue 2, February 2021, Pages: e32
Merkel cell carcinoma (MCC) is a rare but aggressive skin cancer with a high risk of returning and spreading. It affects about 2500 new patients every year in the USA.
Can fish?oil supplementation help protect the skin against air pollution?
doi : 10.1111/bjd.19724
Volume 184, Issue 2, February 2021, Pages: e33
Fine particulate matter (PM2·5) air pollution may contribute to a range of skin diseases or disorders. There is an urgent need for exploring a simple and effective way to protect skin health against exposure to PM2·5, especially in areas with severe air pollution. Therefore, we conducted this study in China to evaluate the potential skin protective effects of fish?oil supplementation against PM2·5 exposure.
Epidemiology of psoriasis over time and by age and gender
doi : 10.1111/bjd.19725
Volume 184, Issue 2, February 2021, Pages: e34
Psoriasis is a long?lasting disease involving inflammation of the skin. The extent to which the occurrence of psoriasis varies over time, as well as by gender and with age, has not been systematically explored. Therefore, we – a group of researchers based in Manchester, UK – aimed to perform a systematic review of published studies on variations in psoriasis incidence (the number of new individuals affected by psoriasis during a particular period of time) and prevalence (all individuals affected with the disease at a particular time) over time, as well as by gender and with age.
Current surveys are not enough: an interview?based evaluation of quality of life in patients with cutaneous T?cell lymphoma
doi : 10.1111/bjd.19726
Volume 184, Issue 2, February 2021, Pages: e35
Cutaneous T?cell lymphoma (CTCL) is a rare type of cancer that starts in the skin but can also involve the blood, lymph nodes, and other organs. CTCL is different from other skin cancers, as it may look like a rash that can cover the entire body.
The global burden of chronic urticaria for the patient and society
doi : 10.1111/bjd.19727
Volume 184, Issue 2, February 2021, Pages: e36
Chronic urticaria (CU) affects about 1% of the world population. It occurs in both sexes and all ages, but mostly in young/middle?aged females. It usually lasts for several years (more than a year in 25?75% of patients), and it often takes more than a year before effective management (meaning treatment) is implemented.
The burden of acne across the world
doi : 10.1111/bjd.19728
Volume 184, Issue 2, February 2021, Pages: e37
Acne is one of the most common skin diseases treated across the world. Latest reports suggest acne may be increasing in adolescents and adults, particularly adult females.
Association of COVID?19 with skin diseases and relevant biologics
doi : 10.1111/bjd.19729
Volume 184, Issue 2, February 2021, Pages: e38
There is concern about the association between coronavirus disease 2019 (COVID?19) and skin diseases, or relevant ‘biologics’ – a type of drug used to treat some skin diseases. This study analysed a nationwide dataset relevant to COVID?19 in South Korea.
Measuring the impact of skin disease caused by onchocerciasis (river blindness)
doi : 10.1111/bjd.19730
Volume 184, Issue 2, February 2021, Pages: e39
River blindness, or Onchocerciasis, is classified as a neglected tropical disease or NTD by the World Health Organization (WHO), meaning that it has been formally acknowledged that steps to control or eliminate the disease should be accelerated.
How can we learn more about scabies worldwide?
doi : 10.1111/bjd.19731
Volume 184, Issue 2, February 2021, Pages: e40
Scabies is very common throughout the world. It is caused by a parasitic mite, Sarcoptes scabiei var. hominis, which burrows into the skin and causes intense itching. It is spread by skin?to?skin contact. Children are especially affected.
Study of VT?1161, a new treatment for fungal nail infection
doi : 10.1111/bjd.19732
Volume 184, Issue 2, February 2021, Pages: e41
Fungal infection of the nails (onychomycosis) is a common condition which is hard to cure. Antifungal drugs cannot easily reach the fungus embedded in the nail, and infected nails take months to grow out. Mild cases can sometimes be treated with use of an antifungal liquid applied to the nail, but more severe infections need medicine that can reach all affected areas through the bloodstream. Even these are not always effective, and can cause side?effects such as a skin rash or liver problems, so we need something better.
The global burden of disease of atopic dermatitis from 1990–2017
doi : 10.1111/bjd.19733
Volume 184, Issue 2, February 2021, Pages: e42
Atopic dermatitis (AD; also called atopic eczema) is a common skin disease which can cause a lot of burden. The Global Burden of Disease (GBD) Study provides information on burden of diseases world?wide, including AD. The aim of this study, conducted by a team of researchers and patients from the U.S.A., the U.K. and the Netherlands, was to analyse and report the information on AD from the GBD Study between 1990 and 2017.
??????: ?? Merkel ??????????
doi : 10.1111/bjd.19734
Volume 184, Issue 2, February 2021, Pages: e43
Merkel ??? (MCC) ??????????????, ??????????????, ??? 2500 ?????????
????????????????????
doi : 10.1111/bjd.19735
Volume 184, Issue 2, February 2021, Pages: e44
???? (PM2·5) ?????????????????????????????????? PM2·5 ?????????????, ????????????????, ????????????, ????????? PM2·5 ????????????
???????????????????
doi : 10.1111/bjd.19736
Volume 184, Issue 2, February 2021, Pages: e45
?????????????????????????????????????????????????, ???????????????????????????? (????????????) ???? (??????????????????) ????????????????????????????
???????: ??????? T ?????????????
doi : 10.1111/bjd.19737
Volume 184, Issue 2, February 2021, Pages: e46
?? T ????? (CTCL) ??????????, ?????, ?????????????????CTCL ????????, ????????????????????
????????????????
doi : 10.1111/bjd.19738
Volume 184, Issue 2, February 2021, Pages: e47
????? (CU) ?????? 1% ??????????????, ????????/?????????????????? (25?75% ???????) , ???????????????????? (???) ?
????????????
doi : 10.1111/bjd.19739
Volume 184, Issue 2, February 2021, Pages: e48
??????????????????????, ??????? (???????) ?????????
? COVID?19 ???????????????
doi : 10.1111/bjd.19740
Volume 184, Issue 2, February 2021, Pages: e49
2019 ?????? (COVID?19) ?????????“????” (???????????????) ?????????????????? COVID?19 ????????????
??????? (???) ?????????
doi : 10.1111/bjd.19741
Volume 184, Issue 2, February 2021, Pages: e50
???????????????? (WHO) ??????????? (? NTD), ?????????????????????????
???????????????
doi : 10.1111/bjd.19742
Volume 184, Issue 2, February 2021, Pages: e51
?????????????????? (Sarcoptes scabiei var. hominis, ???) ???, ?????????????????????????, ?????????
??????????? VT?1161 ???
doi : 10.1111/bjd.19743
Volume 184, Issue 2, February 2021, Pages: e52
????? (????) ?????????????????????????????????, ?????????????????????????????????????????, ??????????????????????????????????????, ??????????????????, ????????????
